OmniAb (OABI) Financials: Revenue & Earnings

OABI price $5.13 +0.17 +3.43%

Ticker
OABI
Price
$5.13
Change
+0.17 +3.43%
Market cap ?
$745.85M
Beta ?
1.05
Sector
Healthcare
Industry
Biotechnology

Fair value

OABI fair value $1.69. Price $5.13. Price is 203% above fair value.

Above fair value, and more expensive than usual. A larger premium than on 69% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 3.48M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.08% (beta 1.05). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 145.39M. Net debt -5.19M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare OABI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-30—-0.12—3.49M
2026-08-06-0.05-0.1213.41M4.69M
2026-05-07-0.06-0.1014.43M5.60M
2026-03-04-0.11-0.088.38M9.00M
2025-11-04-0.14-0.142.24M5.64M
2025-08-06-0.15-0.143.90M5.64M
2025-05-08-0.17-0.174.15M4.49M
2025-03-18-0.12-0.1310.80M6.53M
2024-11-12-0.16-0.144.17M10.13M
2024-08-08-0.13-0.187.61M5.76M
2024-05-09-0.19-0.173.80M5.87M
2024-03-20-0.14-0.174.82M7.46M
2023-11-09-0.16-0.145.48M10.33M
2023-08-10-0.15-0.116.95M11.91M
2023-05-11-0.060.0516.92M18.98M
2023-03-300.070.0235.34M28.02M
2022-11-10-0.11-0.046.91M6.91M
2022-08-12-0.03—7.20M—
2022-05-20-0.05—9.62M—
2022-03-28-0.00—6.28M—
2022-03-25-0.13—21.56M—
2021-06-30-0.08—5.58M—
2021-03-31-0.00—6.60M—
2020-12-31-0.00—13.33M—
2020-09-30-0.06—4.99M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-01Nwachuku Amechi EkekeBuy800.00K$1.981.58M
2026-07-13Nwachuku Amechi EkekeOther0——
2026-06-17Bertozzi Carolyn RBuy20.00K——
2026-06-17Bertozzi Carolyn RBuy40.00K$2.0381.20K
2026-06-17Bertozzi Carolyn RBuy20.00K——
2026-06-17Bertozzi Carolyn RSell20.00K——
2026-06-17Cochran Jennifer R.Buy20.00K——
2026-06-17Cochran Jennifer R.Buy40.00K$2.0381.20K
2026-06-17Cochran Jennifer R.Buy20.00K——
2026-06-17Cochran Jennifer R.Sell20.00K——
2026-06-17Crouse Steven C.Buy20.00K——
2026-06-17Crouse Steven C.Buy40.00K$2.0381.20K
2026-06-17Crouse Steven C.Buy20.00K——
2026-06-17Crouse Steven C.Sell20.00K——
2026-06-17Gotwals Philip JBuy20.00K——
2026-06-17Gotwals Philip JBuy40.00K$2.0381.20K
2026-06-17Gotwals Philip JBuy20.00K——
2026-06-17Gotwals Philip JSell20.00K——
2026-06-17HIGGINS JOHN LBuy20.00K——
2026-06-17HIGGINS JOHN LBuy40.00K$2.0381.20K
2026-06-17HIGGINS JOHN LBuy20.00K——
2026-06-17HIGGINS JOHN LSell20.00K——
2026-06-17Love StevenBuy20.00K——
2026-06-17Love StevenBuy40.00K$2.0381.20K
2026-06-17Love StevenBuy20.00K——
2026-06-17Love StevenSell20.00K——
2026-04-21Gotwals Philip JSell13.33K——
2026-04-21Gotwals Philip JBuy13.33K——
2026-04-21Crouse Steven C.Sell13.33K——
2026-04-21Crouse Steven C.Buy13.33K——
2026-04-07FOEHR MATTHEW WBuy36.46K——
2026-04-07FOEHR MATTHEW WSell19.24K$1.4928.67K
2026-04-07FOEHR MATTHEW WSell36.46K——
2026-04-07GUSTAFSON KURT ABuy13.54K——
2026-04-07GUSTAFSON KURT ASell6.91K$1.4910.30K
2026-04-07GUSTAFSON KURT ASell13.54K——
2026-04-07Berkman Charles SBuy13.54K——
2026-04-07Berkman Charles SSell7.16K$1.4910.66K
2026-04-07Berkman Charles SSell13.54K——
2026-02-18Berkman Charles SBuy600.00K$1.711.03M
2026-02-18Berkman Charles SBuy18.75K——
2026-02-18Berkman Charles SSell9.67K$1.7116.54K
2026-02-18Berkman Charles SBuy60.00K——
2026-02-18Berkman Charles SSell18.75K——
2026-02-18GUSTAFSON KURT ABuy600.00K$1.711.03M
2026-02-18GUSTAFSON KURT ABuy18.75K——
2026-02-18GUSTAFSON KURT ASell9.30K$1.7115.90K
2026-02-18GUSTAFSON KURT ABuy60.00K——
2026-02-18GUSTAFSON KURT ASell18.75K——
2026-02-18FOEHR MATTHEW WBuy58.33K——
2026-02-18FOEHR MATTHEW WSell30.84K$1.7152.74K
2026-02-18FOEHR MATTHEW WBuy1.56M$1.712.67M
2026-02-18FOEHR MATTHEW WBuy156.25K——
2026-02-18FOEHR MATTHEW WSell58.33K——
2026-02-17FOEHR MATTHEW WSell20.75K$1.7035.28K
2026-02-17GUSTAFSON KURT ASell6.83K$1.7011.61K
2026-02-17Berkman Charles SSell6.99K$1.7011.88K
2026-02-16FOEHR MATTHEW WBuy36.46K——
2026-02-16FOEHR MATTHEW WSell36.46K——
2026-02-16GUSTAFSON KURT ABuy13.54K——
2026-02-16GUSTAFSON KURT ASell13.54K——
2026-02-16Berkman Charles SBuy13.54K——
2026-02-16Berkman Charles SSell13.54K——
2026-01-30HIGGINS JOHN LBuy13.17K——
2026-01-30HIGGINS JOHN LSell13.17K——
2025-12-08Berkman Charles SSell8.04K$1.9615.77K
2025-12-08GUSTAFSON KURT ASell23.92K$1.9646.89K
2025-12-08FOEHR MATTHEW WSell13.67K$1.9626.79K
2025-12-07Berkman Charles SBuy15.62K——
2025-12-07Berkman Charles SSell15.62K——
2025-12-07GUSTAFSON KURT ABuy46.50K——
2025-12-07GUSTAFSON KURT ASell46.50K——
2025-12-07FOEHR MATTHEW WBuy26.55K——
2025-12-07FOEHR MATTHEW WSell26.55K——
2025-11-07HIGGINS JOHN LBuy41.04K$1.3856.63K
2025-11-06HIGGINS JOHN LBuy36.22K$1.4151.07K
2025-11-01Bertozzi Carolyn RBuy17.77K——
2025-11-01Bertozzi Carolyn RSell17.77K——
2025-11-01Love StevenBuy13.33K——
2025-11-01Love StevenSell13.33K——
2025-08-26FOEHR MATTHEW WBuy540.54K$1.851000.00K
2025-06-17Love StevenBuy20.00K——
2025-06-17Love StevenBuy20.00K——
2025-06-17Love StevenBuy40.00K$1.7068.00K
2025-06-17Love StevenSell20.00K——
2025-06-17HIGGINS JOHN LBuy20.00K——
2025-06-17HIGGINS JOHN LBuy40.00K$1.7068.00K
2025-06-17HIGGINS JOHN LBuy20.00K——
2025-06-17HIGGINS JOHN LSell20.00K——
2025-06-17Gotwals Philip JBuy20.00K——
2025-06-17Gotwals Philip JBuy40.00K$1.7068.00K
2025-06-17Crouse Steven C.Buy20.00K——
2025-06-17Crouse Steven C.Buy40.00K$1.7068.00K
2025-06-17Cochran Jennifer R.Buy20.00K——
2025-06-17Cochran Jennifer R.Buy40.00K$1.7068.00K
2025-06-17Cochran Jennifer R.Buy20.00K——
2025-06-17Cochran Jennifer R.Sell20.00K——
2025-06-17Bertozzi Carolyn RBuy20.00K——
2025-06-17Bertozzi Carolyn RBuy40.00K$1.7068.00K
2025-06-17Bertozzi Carolyn RBuy20.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 135, holders +5 vs prior quarter. Ownership 46.40%.

HolderSharesChangeChange %Value
WHITEFORT CAPITAL MANAGEMENT, LP10.25M-3.98M-27.95%25.21M
BLACKROCK, INC.8.90M790.61K+9.75%21.89M
NOMURA HOLDINGS INC5.03M4.32M+613.17%12.37M
CADIAN CAPITAL MANAGEMENT, LP4.21M54.69K+1.32%10.36M
VANGUARD CAPITAL MANAGEMENT LLC3.85M-141.30K-3.54%9.48M
GEODE CAPITAL MANAGEMENT, LLC2.88M-41.60K-1.42%7.10M
RICE HALL JAMES & ASSOCIATES, LLC2.61M63.18K+2.48%6.42M
PRIVATE MANAGEMENT GROUP INC2.34M-84.40K-3.47%5.77M
STATE STREET CORP2.13M66.41K+3.21%5.25M
DIMENSIONAL FUND ADVISORS LP1.26M-483.15K-27.68%3.11M
TOWERVIEW LLC1.18M180.00K+18.00%2.90M
VANGUARD PORTFOLIO MANAGEMENT LLC980.42K76.62K+8.48%2.41M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC966.88K7.30K+0.76%2.38M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.966.88K966.88KNew2.38M
NORTHERN TRUST CORP948.29K67.40K+7.65%2.33M
ADAR1 CAPITAL MANAGEMENT, LLC947.41K242.22K+34.35%2.33M
ISTHMUS PARTNERS, LLC803.43K46.75K+6.18%1.98M
VANGUARD FIDUCIARY TRUST CO758.46K32.85K+4.53%1.87M
TWO SIGMA INVESTMENTS, LP657.43K144.69K+28.22%1.62M
NUVEEN, LLC642.81K18.93K+3.04%1.58M
RENAISSANCE TECHNOLOGIES LLC600.35K330.75K+122.68%1.48M
D. E. SHAW & CO., INC.559.40K179.15K+47.11%1.38M
MACKENZIE FINANCIAL CORP489.13K489.13KNew1.20M
GOLDMAN SACHS GROUP INC384.57K-34.45K-8.22%946.05K
MORGAN STANLEY371.51K-36.43K-8.93%913.90K

Earnings and financials

OmniAb, Inc. (OABI) trades at $5.13, with a market cap of $745.85M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

OmniAb (OABI) Financials: Revenue & Earnings

OABI$5.13+0.17 +3.43%

$745.85M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History